Erythropoietin-driven signaling ameliorates the survival defect of DMT1-mutant erythroid progenitors and erythroblasts.

Haematologica
Monika HorvathovaVladimir Divoky

Abstract

Hypochromic microcytic anemia associated with ineffective erythropoiesis caused by recessive mutations in divalent metal transporter 1 (DMT1) can be improved with high-dose erythropoietin supplementation. The aim of this study was to characterize and compare erythropoiesis in samples from a DMT1-mutant patient before and after treatment with erythropoietin, as well as in a mouse model with a DMT1 mutation, the mk/mk mice. Colony assays were used to compare the in vitro growth of pre-treatment and post-treatment erythroid progenitors in a DMT1-mutant patient. To enable a comparison with human data, high doses of erythropoietin were administered to mk/mk mice. The apoptotic status of erythroblasts, the expression of anti-apoptotic proteins, and the key components of the bone marrow-hepcidin axis were evaluated. Erythropoietin therapy in vivo or the addition of a broad-spectrum caspase inhibitor in vitro significantly improved the growth of human DMT1-mutant erythroid progenitors. A decreased number of apoptotic erythroblasts was detected in the patient's bone marrow after erythropoietin treatment. In mk/mk mice, erythropoietin administration increased activation of signal transducer and activator of transcription 5 (STAT5) and re...Continue Reading

References

Apr 1, 1978·The Journal of Clinical Investigation·J F PrchalP J Fialkow
Aug 1, 1972·British Journal of Haematology·R M BannermanE S Russell
Aug 1, 1997·Nature Genetics·J V Gray, K J Johnson
Feb 27, 1999·Journal of Cellular Physiology·P A Gregoli, M C Bondurant
Feb 15, 2002·Current Opinion in Hematology·Stanley L Schrier
Aug 18, 2004·Current Opinion in Hematology·Tomas Ganz
Apr 26, 2005·The Journal of Clinical Investigation·Hiromi GunshinNancy C Andrews
Sep 6, 2005·Blood·Hiromi GunshinJosef Prchal
Dec 15, 2006·Nature·Jean-Antoine RibeilOlivier Hermine
Mar 22, 2007·Kidney & Blood Pressure Research·Josef ZadrazilMiroslav Hrubý
Dec 25, 2007·The Journal of Pediatrics·A IolasconC Beaumont
Mar 20, 2008·Blood·Pradeep SathyanarayanaDon M Wojchowski
Jun 26, 2009·Blood Cells, Molecules & Diseases·Esther BlancoCarole Beaumont
Feb 26, 2010·Current Opinion in Hematology·Toshihiko TannoJeffery L Miller
Feb 25, 2011·Blood·Tomas Ganz

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anemia

Anemia develops when your blood lacks enough healthy red blood cells. Anemia of inflammation (AI, also called anemia of chronic disease) is a common, typically normocytic, normochromic anemia that is caused by an underlying inflammatory disease. Here is the latest research on anemia.

Apoptotic Caspases

Apoptotic caspases belong to the protease enzyme family and are known to play an essential role in inflammation and programmed cell death. Here is the latest research.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis